Epiphany Biosciences Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $36.2M
Latest Deal Amount
  • Investors
  • 4

Epiphany Biosciences General Information

Description

Developer of antiviral therapeutics to to prevent the spread of varicella zoster virus (VZV), epstein-barr virus (EBV) and hepatitis C virus (HCV).

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • One California Street
  • Suite 2800
  • San Francisco, CA 94111
  • United States
+1 (415) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Epiphany Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 14-Mar-2007 $36.2M 000.00 0000 Completed Startup
To view Epiphany Biosciences’s complete valuation and funding history, request access »

Epiphany Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00 00 00 00 00.000
To view Epiphany Biosciences’s complete cap table history, request access »

Epiphany Biosciences Executive Team (4)

Name Title Board Seat Contact Info
Fred Volinsky MD Chief Executive Officer, Co-Founder and Chairman
Michael Houghton Chief Scientific Officer
Steve Blank Co-Founder
To view Epiphany Biosciences’s complete executive team members history, request access »

Epiphany Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CDIB BioScience Venture Management Venture Capital Minority 000 0000 000000 0
Global Trust Ventures PE/Buyout Minority 000 0000 000000 0
Wexford Capital Asset Manager Minority 000 0000 000000 0
Windsor Bay Capital Other Minority 000 0000 000000 0
To view Epiphany Biosciences’s complete investors history, request access »